Chinese scientists, with the aim of enhancing leukemia treatment, have developed a kind of "double-sided tape" that helps the ...

KOMO Biosciences, a developer of non-viral targeted insertion technologies, today announced that it has granted Syngenta, a world leader in agricultural innovation, a Research Evaluation License to ...

Strain hunters The laboratory for infections with a natural reservoir at the Republican Centre for Hygiene, Epidemiology ...

Recently published Epidermolysis Bullosa Market Insights report includes a comprehensive understanding of current treatment practices, epidermolysis bullosa emerging drugs, market share of individual ...

The global obesity drugs market is projected to grow at a robust compound annual growth rate (CAGR) of approximately 25% ...

On the brink of the first genetically engineered (GE) wheat to be introduced into the U.S. market, after the U.S. Department ...

Picture this: You're signing a credit card receipt at the bank, using one of those pens attached to a short chain. As a ...

The trajectory of base editing has been remarkable, progressing from the laboratory to patient care, treating debilitating or ...

INSTALL results showed successful and safe non-viral insertion of large genetic payloads in the livers of mice when delivered by lipid nanoparticles (LNPs). In contrast, mice experienced fatal immune ...

Wildlife populations that become small and isolated, often due to habitat loss, inevitably experience inbreeding which can ...

Our limited understanding of the metabolism of our microbial ancestor is a sizeable gap in our knowledge of how complex life ...

When a virus infects a bacterial cell, the viral genome is the first component to be fully injected into the cell, making it an ideal immune target. A bacterial enzyme anchored to the membrane ...